Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoya Hara

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
European Journal of Pharmacology|December 23, 2017
Inhibition of activated factor X by rivaroxaban attenuates neointima formation after wire-mediated vascular injuryTomoya Hara, Daiju Fukuda, Kimie Tanaka, et al.
Journal of Medical Ultrasonics (2001)|June 10, 2016
Massive tricuspid regurgitation due to pacemaker-lead puncture of the tricuspid valve: successful diagnosis by 3-dimensional echocardiographyRina Tamai, Tomoya Hara, Hirotsugu Yamada, et al.
The Journal of Medical Investigation : JMI|October 6, 2012
Bicuspid aortic valve endocarditis complicated by perivalvular abscessTomoya Hara, Takeshi Soeki, Toshiyuki Niki, et al.
The Journal of Medical Investigation : JMI|April 23, 2026
Hematoma Causing Iliac Vein Compression Mimicking Deep Vein Thrombosis in an Elderly Patient with Hip ArthroplastyShusuke Yagi, Eriko Nasu, Kaori Inaba, et al.
The Journal of Medical Investigation : JMI|November 8, 2023
Lipoprotein (a) is a risk factor of aortic valve calcification in patients with a risk of atherosclerosisMunkhtsetseg Tserensonom, Shusuke Yagi, Takayuki Ise, et al.
Atherosclerosis|March 31, 2015
Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient miceTomoya Hara, Daiju Fukuda, Kimie Tanaka, et al.
Diabetology & Metabolic Syndrome|February 28, 2014
Association of lower limb muscle mass and energy expenditure with visceral fat mass in healthy menShusuke Yagi, Muneyuki Kadota, Ken-Ichi Aihara, et al.
Heart and Vessels|July 18, 2023
Olive mill wastewater and hydroxytyrosol inhibits atherogenesis in apolipoprotein E-deficient miceTomoya Hara, Daiju Fukuda, Byambasuren Ganbaatar, et al.
Therapeutic Innovation & Regulatory Science|November 5, 2024
Principles for Evaluating the Efficacy and Safety of Ceramic Dental Implants in JapanTomoya Hara, Yuchi Sato, Hiroyuki Tanishiro, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 22, 2021
Activated Factor X Signaling Pathway via Protease-Activated Receptor 2 Is a Novel Therapeutic Target for Preventing Atrial FibrillationTomomi Matsuura, Takeshi Soeki, Daiju Fukuda, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
European Journal of Pharmacology|December 23, 2017
Inhibition of activated factor X by rivaroxaban attenuates neointima formation after wire-mediated vascular injuryTomoya Hara, Daiju Fukuda, Kimie Tanaka, et al.
Journal of Medical Ultrasonics (2001)|June 10, 2016
Massive tricuspid regurgitation due to pacemaker-lead puncture of the tricuspid valve: successful diagnosis by 3-dimensional echocardiographyRina Tamai, Tomoya Hara, Hirotsugu Yamada, et al.
The Journal of Medical Investigation : JMI|October 6, 2012
Bicuspid aortic valve endocarditis complicated by perivalvular abscessTomoya Hara, Takeshi Soeki, Toshiyuki Niki, et al.
The Journal of Medical Investigation : JMI|April 23, 2026
Hematoma Causing Iliac Vein Compression Mimicking Deep Vein Thrombosis in an Elderly Patient with Hip ArthroplastyShusuke Yagi, Eriko Nasu, Kaori Inaba, et al.
The Journal of Medical Investigation : JMI|November 8, 2023
Lipoprotein (a) is a risk factor of aortic valve calcification in patients with a risk of atherosclerosisMunkhtsetseg Tserensonom, Shusuke Yagi, Takayuki Ise, et al.
Atherosclerosis|March 31, 2015
Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient miceTomoya Hara, Daiju Fukuda, Kimie Tanaka, et al.
Diabetology & Metabolic Syndrome|February 28, 2014
Association of lower limb muscle mass and energy expenditure with visceral fat mass in healthy menShusuke Yagi, Muneyuki Kadota, Ken-Ichi Aihara, et al.
Heart and Vessels|July 18, 2023
Olive mill wastewater and hydroxytyrosol inhibits atherogenesis in apolipoprotein E-deficient miceTomoya Hara, Daiju Fukuda, Byambasuren Ganbaatar, et al.
Therapeutic Innovation & Regulatory Science|November 5, 2024
Principles for Evaluating the Efficacy and Safety of Ceramic Dental Implants in JapanTomoya Hara, Yuchi Sato, Hiroyuki Tanishiro, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 22, 2021
Activated Factor X Signaling Pathway via Protease-Activated Receptor 2 Is a Novel Therapeutic Target for Preventing Atrial FibrillationTomomi Matsuura, Takeshi Soeki, Daiju Fukuda, et al.
Pageof 6